加载中…
我们覆盖的 596 家公司，其中 361 家已评级
这里每家公司都经过同样的五项成长与现金创造检验。它描述的是这个行业今天申报出来的样子——而不是该买其中哪一家。
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | US$133.4B | US$526.19 | 30.65 | US$12.6B | 35.0% |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | US$84.2B | US$788.04 | 19.47 | US$15.5B | 27.9% |
| MRNA | Moderna, Inc. | D- | US$79.4B | US$198.88 | — | US$2.2B | -141.4% |
| LGVN | LONGEVERON INC. | F- | US$79B | US$2.81 | — | US$1.2M | -1,977.6% |
| ARGX | ARGENX SE | 未评级 | US$59.4B | US$959.49 | 49.03 | — | — |
| RVMD | Revolution Medicines, Inc. | F | US$43.9B | US$204.97 | — | US$0.00 | — |
| ONC | BEONE MEDICINES LTD. | A+ | US$41B | US$360.85 | 64.55 | US$6.1B | 10.7% |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | A+ | US$34.2B | US$255.96 | 129.93 | US$3.7B | 19.7% |
| RPRX | Royalty Pharma plc | B+ | US$32.4B | US$58.21 | 30.96 | US$2.5B | 32.1% |
| NCNA | NUCANA PLC | 未评级 | US$26.6B | US$1.28 | — | — | — |
| ROIV | ROIVANT SCIENCES LTD. | F- | US$25.9B | US$35.80 | — | US$7.5M | -3,535.0% |
| INSM | INSMED INC | C- | US$25.7B | US$117.83 | — | US$1.1B | -76.9% |
| INCY | INCYTE CORPORATION | A+ | US$24.8B | US$123.89 | 17.50 | US$5.4B | 26.7% |
| BNTX | BioNTech SE | D | US$24.7B | US$98.52 | — | US$3B | -42.9% |
| JAZZ | Jazz Pharmaceuticals plc | A+ | US$15.4B | US$237.95 | 16.26 | US$4.6B | 20.4% |
| AKTX | Akari Therapeutics, Plc | 未评级 | US$15.2B | US$9.76 | — | — | — |
| EXEL | Exelixis Inc | A+ | US$14.4B | US$58.16 | 18.29 | US$2.4B | 35.3% |
| ASND | Ascendis Pharma A/S | D | US$14B | US$225.60 | — | US$1.2B | -21.8% |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | US$12.9B | US$113.90 | 33.21 | US$1.7B | 24.9% |
| BBIO | BridgeBio Pharma, Inc. | B | US$12.8B | US$65.57 | — | US$713.1M | -98.5% |
| CORT | CORCEPT THERAPEUTICS INC | C | US$12.6B | US$116.10 | 276.43 | US$830.8M | 6.6% |
| SMMT | Summit Therapeutics Inc. | F | US$12.5B | US$15.61 | — | US$0.00 | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | C- | US$11.9B | US$516.56 | — | US$1.3B | -25.3% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | A | US$11.7B | US$60.26 | 162.86 | US$3.4B | 2.1% |
| TWST | Twist Bioscience Corporation | C- | US$11.5B | US$182.83 | — | US$431.8M | -31.7% |
| TECH | BIO-TECHNE Corp | B+ | US$11.4B | US$72.61 | 63.14 | US$1.2B | 15.0% |
| KRYS | Krystal Biotech, Inc. | A+ | US$10.2B | US$345.82 | 43.34 | US$440.5M | 54.8% |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | US$10.2B | US$195.09 | — | US$776.6M | -24.7% |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | D- | US$9.3B | US$65.92 | — | US$669.5M | -47.8% |
| KYMR | KYMERA THERAPEUTICS, INC. | D- | US$9.3B | US$111.95 | — | US$105M | -285.3% |
| PTGX | Protagonist Therapeutics, Inc | A+ | US$9.2B | US$141.86 | 139.08 | US$282M | 29.4% |
| CAI | CARIS LIFE SCIENCES, INC. | A+ | US$9B | US$31.98 | 18.92 | US$989.6M | 10.6% |
| CYTK | CYTOKINETICS, INCORPORATED | F | US$9B | US$64.66 | — | US$67.7M | -1,321.1% |
| IBRX | IMMUNITYBIO, INC. | B | US$8.9B | US$8.44 | — | US$165.8M | -598.6% |
| TGTX | TG THERAPEUTICS, INC. | A+ | US$8.8B | US$57.43 | 20.88 | US$799.5M | 55.2% |
| PCVX | VAXCYTE, INC. | 未评级 | US$8.4B | US$56.21 | — | — | — |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | US$7.8B | US$280.78 | — | US$0.00 | — |
| GPCR | Structure Therapeutics Inc. | 未评级 | US$7.7B | US$35.93 | — | — | — |
| SYRE | SPYRE THERAPEUTICS, INC. | F | US$7.6B | US$85.69 | — | US$0.00 | — |
| IONS | Ionis Pharmaceuticals, Inc. | F- | US$7.4B | US$44.50 | — | US$874.1M | -64.7% |
| ABVX | Abivax S.A. | 未评级 | US$7.2B | US$91.06 | — | — | — |
| IMVT | IMMUNOVANT, INC. | 未评级 | US$6.9B | US$33.30 | — | — | — |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | US$6.8B | US$98.66 | — | US$239.9M | -85.6% |
| BLTE | Belite Bio, Inc | 未评级 | US$6.6B | US$167.33 | — | — | — |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | A+ | US$6B | US$301.52 | 32.04 | US$290.5M | 67.9% |
| CGON | CG Oncology, Inc. | D- | US$6B | US$67.15 | — | US$6.2M | -3,602.7% |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F | US$5.9B | US$48.63 | — | US$0.00 | — |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | US$5.8B | US$89.70 | — | US$618.1M | -139.2% |
| COGT | Cogent Biosciences, Inc. | 未评级 | US$5.6B | US$32.31 | — | — | — |
| TVTX | TRAVERE THERAPEUTICS, INC. | D- | US$5.6B | US$59.44 | — | US$591.3M | -7.4% |
| ORKA | Oruka Therapeutics, Inc. | 未评级 | US$5.6B | US$84.46 | — | — | — |
| GOSS | GOSSAMER BIO, INC. | B | US$5.3B | US$10.94 | — | US$53.3M | -235.0% |
| CRSP | CRISPR THERAPEUTICS AG | F- | US$5.2B | US$54.23 | — | US$13.4M | -3,368.7% |
| PTCT | PTC Therapeutics, Inc. | D | US$5.2B | US$62.67 | — | US$1B | -3.8% |
| ERAS | Erasca, Inc. | 未评级 | US$5B | US$14.25 | — | — | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | US$5B | US$11.00 | — | US$325M | -89.1% |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | F- | US$5B | US$88.55 | — | US$2M | -9,442.3% |
| MANE | Veradermics, Inc | 未评级 | US$4.9B | US$116.57 | — | — | — |
| DFTX | Definium Therapeutics, Inc. | 未评级 | US$4.9B | US$36.17 | — | — | — |
| EWTX | Edgewise Therapeutics, Inc. | 未评级 | US$4.3B | US$39.34 | — | — | — |
| TNGX | Tango Therapeutics, Inc. | F- | US$4.2B | US$24.92 | — | US$53.8M | -229.9% |
| VKTX | Viking Therapeutics, Inc. | F | US$4.1B | US$35.56 | — | US$0.00 | — |
| ABCL | AbCellera Biologics Inc. | D- | US$3.9B | US$12.70 | — | US$66.2M | -248.8% |
| CELC | CELCUITY INC. | 未评级 | US$3.9B | US$79.52 | — | — | — |
| TLX | Telix Pharmaceuticals Limited | D- | US$3.9B | US$11.45 | — | US$803.8M | -0.9% |
| RLAY | Relay Therapeutics, Inc. | C- | US$3.8B | US$17.47 | — | US$10.4M | -2,763.6% |
| XENE | XENON PHARMACEUTICALS INC. | F | US$3.6B | US$36.94 | — | US$0.00 | — |
| ACAD | ACADIA PHARMACEUTICALS INC. | A+ | US$3.6B | US$20.68 | 9.27 | US$1.1B | 33.4% |
| IDYA | IDEAYA Biosciences, Inc. | D- | US$3.5B | US$36.69 | — | US$234.1M | -74.8% |
| LEGN | Legend Biotech Corp | C- | US$3.5B | US$19.11 | — | US$1B | -24.6% |
| DBVT | DBV Technologies S.A. | F- | US$3.4B | US$11.56 | — | US$5M | -3,506.5% |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | A | US$3.4B | US$26.92 | 128.19 | US$464M | 6.1% |
| TARS | TARSUS PHARMACEUTICALS, INC. | A | US$3.3B | US$75.69 | — | US$606.3M | -7.7% |
| ELVN | ENLIVEN THERAPEUTICS, INC. | 未评级 | US$3.3B | US$44.75 | — | — | — |
| DNLI | Denali Therapeutics Inc. | F- | US$3.3B | US$20.39 | — | US$3.6M | -14,191.2% |
| RCUS | Arcus Biosciences, Inc. | D- | US$3.2B | US$24.97 | — | US$117M | -393.2% |
| DYN | Dyne Therapeutics, Inc. | 未评级 | US$3B | US$16.03 | — | — | — |
| PGEN | PRECIGEN, INC. | F- | US$2.8B | US$7.75 | — | US$9.7M | -1,628.5% |
| NAMS | NewAmsterdam Pharma Company N.V. | F- | US$2.7B | US$22.58 | — | US$7.1M | -3,644.2% |
| MBX | MBX Biosciences, Inc. | 未评级 | US$2.6B | US$53.63 | — | — | — |
| BEAM | Beam Therapeutics Inc. | C- | US$2.5B | US$24.27 | — | US$156M | -54.7% |
| IRON | Disc Medicine, Inc. | 未评级 | US$2.5B | US$65.24 | — | — | — |
| CLDX | Celldex Therapeutics, Inc. | F- | US$2.4B | US$31.10 | — | US$158K | -190,220.9% |
| IMNM | Immunome, Inc. | F | US$2.4B | US$21.41 | — | US$0.00 | — |
| QURE | uniQure N.V. | C- | US$2.4B | US$38.23 | — | US$18.1M | -1,154.4% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | A+ | US$2.4B | US$41.26 | 13.35 | US$959.9M | 18.9% |
| NRIX | NURIX THERAPEUTICS, INC. | F- | US$2.4B | US$23.01 | — | US$36.8M | -928.4% |
| VERA | Vera Therapeutics, Inc. | 未评级 | US$2.3B | US$32.54 | — | — | — |
| SLS | SELLAS Life Sciences Group, Inc. | 未评级 | US$2.3B | US$11.61 | — | — | — |
| VRDN | Viridian Therapeutics, Inc./DE | D- | US$2.3B | US$20.47 | — | US$71.1M | -544.1% |
| MLYS | MINERALYS THERAPEUTICS, INC. | 未评级 | US$2.3B | US$25.86 | — | — | — |
| GMAB | Genmab A/S | A+ | US$2.2B | US$35.32 | 2.30 | US$3.7B | 25.9% |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | US$2.2B | US$16.44 | 7.18 | US$311.5M | 100.8% |
| OCUL | OCULAR THERAPEUTIX, INC | F- | US$2.1B | US$9.65 | — | US$52.1M | -579.1% |
| ADMA | ADMA BIOLOGICS, INC. | A+ | US$2.1B | US$9.38 | 13.40 | US$512.3M | 33.0% |
| PHVS | Pharvaris N.V. | 未评级 | US$2.1B | US$32.02 | — | — | — |
| TRVI | Trevi Therapeutics, Inc. | 未评级 | US$2.1B | US$14.41 | — | — | — |
| VCEL | VERICEL CORPORATION | A | US$2B | US$39.71 | 84.49 | US$306.3M | 7.9% |
| KOD | KODIAK SCIENCES INC. | 未评级 | US$2B | US$32.35 | — | — | — |
| URGN | UroGen Pharma Ltd. | C | US$2B | US$41.35 | — | US$188.7M | -51.7% |
| NUVB | Nuvation Bio Inc. | C- | US$2B | US$5.74 | — | US$169.9M | -88.2% |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | US$2B | US$3.74 | — | US$54.9M | -945.9% |
| PVLA | Palvella Therapeutics, Inc. | 未评级 | US$2B | US$138.16 | — | — | — |
| SRPT | SAREPTA THERAPEUTICS, INC. | B- | US$2B | US$18.67 | — | US$2B | -6.9% |
| BHVN | Biohaven Ltd. | 未评级 | US$2B | US$12.99 | — | — | — |
| MESO | MESOBLAST LIMITED | C- | US$2B | US$15.12 | — | US$65.4M | -156.2% |
| NKTR | Nektar Therapeutics | F- | US$1.9B | US$57.06 | — | US$54.6M | -287.8% |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | US$1.9B | US$32.58 | — | US$98.3M | -418.2% |
| GENB | Generate Biomedicines, Inc. | 未评级 | US$1.9B | US$15.15 | — | — | — |
| LKFT | GALAPAGOS NV | B | US$1.9B | US$29.38 | 5.30 | US$1.3B | 28.9% |
| FTRE | FORTREA HOLDINGS INC. | C | US$1.9B | US$19.89 | — | US$2.7B | -3.2% |
| ZYME | ZYMEWORKS INC. | F- | US$1.9B | US$26.52 | — | US$37.1M | -404.0% |
| VIR | Vir Biotechnology, Inc. | C- | US$1.8B | US$10.66 | — | US$303.2M | -83.0% |
| XNCR | Xencor, Inc | F- | US$1.8B | US$23.80 | — | US$105M | -155.6% |
| SEPN | Septerna, Inc. | B | US$1.8B | US$37.77 | — | US$98.9M | -24.5% |
| ZBIO | Zenas BioPharma, Inc. | F- | US$1.8B | US$26.95 | — | US$10M | -4,843.8% |
| NVAX | NOVAVAX INC | D | US$1.8B | US$10.63 | — | US$413.8M | -59.9% |
| ABSI | ABSCI CORP | F- | US$1.7B | US$9.74 | — | US$1.6M | -7,756.4% |
| NTLA | INTELLIA THERAPEUTICS, INC. | C- | US$1.6B | US$11.75 | — | US$59.5M | -672.2% |
| RAPP | Rapport Therapeutics, Inc. | 未评级 | US$1.6B | US$33.91 | — | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | US$1.6B | US$18.20 | — | US$252.3M | -87.5% |
| NBTX | Nanobiotix S.A. | C- | US$1.6B | US$33.31 | — | US$37.1M | -73.5% |
| STOK | Stoke Therapeutics, Inc. | F- | US$1.6B | US$24.80 | — | US$27.6M | -753.6% |
| IMCR | Immunocore Holdings plc | C- | US$1.6B | US$30.72 | — | US$430.8M | -4.2% |
| ANAB | ANAPTYSBIO, INC. | B+ | US$1.5B | US$51.00 | 8.89 | US$237.6M | 82.4% |
| TSHA | Taysha Gene Therapies, Inc. | F- | US$1.5B | US$4.67 | — | US$5.5M | -2,728.0% |
| INVA | INNOVIVA, INC. | B+ | US$1.5B | US$20.74 | 5.05 | US$440M | 81.2% |
| GHRS | GH Research PLC | 未评级 | US$1.5B | US$23.84 | — | — | — |
| INBX | INHIBRX BIOSCIENCES, INC. | D- | US$1.5B | US$99.61 | — | US$1.3M | -10,629.3% |
| OMER | OMEROS CORP | 未评级 | US$1.5B | US$20.08 | 11.67 | — | — |
| MAZE | MAZE THERAPEUTICS, INC. | F- | US$1.4B | US$26.05 | — | US$167.5M | -79.8% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | US$1.4B | US$14.50 | — | US$717.2M | -81.7% |
| AVBP | ARRIVENT BIOPHARMA, INC. | 未评级 | US$1.4B | US$28.45 | — | — | — |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | F- | US$1.4B | US$14.86 | — | US$85.6M | -216.5% |
| ORIC | ORIC PHARMACEUTICALS, INC. | 未评级 | US$1.4B | US$13.16 | — | — | — |
| JAGX | JAGUAR HEALTH, INC. | B | US$1.3B | US$7.70 | — | US$27.8M | -132.2% |
| TYRA | Tyra Biosciences, Inc. | 未评级 | US$1.3B | US$21.76 | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | 未评级 | US$1.3B | US$14.54 | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | 未评级 | US$1.3B | US$20.66 | — | — | — |
| BCAX | Bicara Therapeutics Inc. | 未评级 | US$1.3B | US$19.21 | — | — | — |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | 未评级 | US$1.2B | US$34.42 | — | — | — |
| LBRX | LB Pharmaceuticals Inc | 未评级 | US$1.2B | US$37.33 | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | 未评级 | US$1.2B | US$12.36 | — | — | — |
| IMTX | Immatics N.V. | 未评级 | US$1.1B | US$8.37 | — | — | — |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | US$1.1B | US$7.60 | — | US$208.8M | -37.1% |
| VOR | Vor Biopharma Inc. | 未评级 | US$1.1B | US$18.52 | 0.10 | — | — |
| MNKD | MANNKIND CORP | C | US$1.1B | US$3.34 | — | US$393.6M | -11.1% |
| MGTX | MeiraGTx Holdings plc | A | US$1B | US$10.91 | 15.37 | US$397.5M | 19.9% |
| ANRO | Alto Neuroscience, Inc. | 未评级 | US$1B | US$26.49 | — | — | — |
| SVRA | Savara Inc | 未评级 | US$1B | US$5.00 | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 未评级 | US$1B | US$12.04 | — | — | — |
| AKTS | Aktis Oncology, Inc. | 未评级 | US$1B | US$19.43 | — | — | — |
| GLUE | Monte Rosa Therapeutics, Inc. | D- | US$1B | US$11.77 | — | US$28.7M | -560.8% |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | US$1B | US$14.47 | — | US$92M | -194.7% |
| JANX | Janux Therapeutics, Inc. | B- | US$996.5M | US$16.30 | — | US$24M | -427.5% |
| CRVS | Corvus Pharmaceuticals, Inc. | 未评级 | US$977.5M | US$11.62 | — | — | — |
| ABUS | Arbutus Biopharma Corp | C+ | US$959.6M | US$4.85 | 6.14 | US$181.7M | 84.2% |
| KURA | KURA ONCOLOGY, INC. | D- | US$957.2M | US$10.76 | — | US$77.2M | -384.3% |
| CGEM | CULLINAN THERAPEUTICS, INC. | 未评级 | US$953.1M | US$14.81 | — | — | — |
| JBIO | Jade Biosciences, Inc. | 未评级 | US$917.1M | US$14.42 | — | — | — |
| SGP | SpyGlass Pharma, Inc. | 未评级 | US$905.4M | US$27.07 | — | — | — |
| RIGL | RIGEL PHARMACEUTICALS, INC. | B+ | US$900M | US$48.18 | 2.85 | US$276.8M | 116.3% |
| ALMS | Alumis Inc. | D- | US$897.3M | US$7.10 | — | US$7.4M | -5,933.5% |
| TBPH | Theravance Biopharma, Inc. | B | US$884.2M | US$17.03 | 16.86 | US$104.3M | 51.6% |
| SANA | Sana Biotechnology, Inc. | 未评级 | US$881.6M | US$2.95 | — | — | — |
| APMD | Apnimed, Inc. | 未评级 | US$878M | US$21.09 | — | — | — |
| ARDX | ARDELYX, INC. | B- | US$852.2M | US$3.42 | — | US$450.9M | -12.4% |
| CADL | CANDEL THERAPEUTICS, INC. | 未评级 | US$843.2M | US$11.02 | — | — | — |
| AVTX | AVALO THERAPEUTICS, INC. | F- | US$829.7M | US$15.47 | — | US$59K | -170,055.9% |
| GYRE | Gyre Therapeutics, Inc. | D- | US$819.6M | US$7.35 | — | US$119.4M | -23.6% |
| GERN | GERON CORP | 未评级 | US$809.5M | US$1.26 | — | — | — |
| LXRX | LEXICON PHARMACEUTICALS, INC. | C- | US$798.7M | US$1.80 | — | US$41.5M | -147.4% |
| IMMX | IMMIX BIOPHARMA, INC. | 未评级 | US$784.8M | US$10.97 | — | — | — |
| SLDB | Solid Biosciences Inc. | 未评级 | US$781.7M | US$7.29 | — | — | — |
| ACHV | Achieve Life Sciences, Inc. | 未评级 | US$775.9M | US$7.54 | — | — | — |
| OLMA | OLEMA PHARMACEUTICALS, INC. | 未评级 | US$765.6M | US$8.75 | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | US$758.5M | US$12.12 | — | US$0.00 | — |
| ACRS | Aclaris Therapeutics, Inc. | D- | US$758.1M | US$5.15 | — | US$8.2M | -921.5% |
| WVE | WAVE LIFE SCIENCES LTD. | F- | US$744.8M | US$3.78 | — | US$42.7M | -473.9% |
| PHAR | Pharming Group N.V. | A | US$734M | US$10.46 | 261.50 | US$376.1M | 0.8% |
| ANNX | ANNEXON, INC. | 未评级 | US$719.3M | US$3.64 | — | — | — |
| VSTM | Verastem, Inc. | D- | US$701M | US$7.74 | — | US$87.5M | -231.6% |
| MDXG | MiMedx Group, Inc. | C | US$680.7M | US$4.67 | 116.75 | US$355.2M | 1.8% |
| OABI | OMNIAB, INC. | D- | US$670.2M | US$4.61 | — | US$38.5M | -115.1% |
| CLYM | CLIMB BIO, INC. | 未评级 | US$669.7M | US$11.66 | — | — | — |
| NVCT | Nuvectis Pharma, Inc. | 未评级 | US$658.8M | US$20.22 | — | — | — |
| ZVRA | Zevra Therapeutics, Inc. | A+ | US$655.6M | US$11.04 | 12.00 | US$136.1M | 42.8% |
| IVA | Inventiva S.A. | F | US$651.2M | US$3.37 | — | US$5.1M | -7,899.6% |
| AURA | Aura Biosciences, Inc. | 未评级 | US$622.2M | US$6.00 | — | — | — |
| IBO | Impact BioMedical, INC. | A | US$613.5M | US$5.69 | 6.47 | US$35K | 2,254.3% |
| CRMD | CORMEDIX INC. | A+ | US$611.9M | US$7.85 | 3.83 | US$462.2M | 40.5% |
| STTK | Shattuck Labs, Inc. | C- | US$609.2M | US$6.07 | — | US$1M | -5,256.8% |
| ALT | ALTIMMUNE, INC. | D- | US$595.2M | US$3.06 | — | US$41K | -223,804.9% |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | D- | US$591.2M | US$10.66 | — | US$111.9M | -260.0% |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | US$590.6M | US$7.30 | — | US$239.7M | -41.3% |
| CTMX | CytomX Therapeutics, Inc. | F- | US$588.3M | US$2.70 | — | US$18.3M | -435.2% |
| MNPR | Monopar Therapeutics Inc. | F | US$572.1M | US$85.24 | — | US$0.00 | — |
| ALLO | Allogene Therapeutics, Inc. | B- | US$570.1M | US$1.65 | — | US$6.8M | -2,419.5% |
| NGNE | Neurogene Inc. | F | US$566.5M | US$28.31 | — | US$0.00 | — |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | 未评级 | US$545.6M | US$2.57 | — | — | — |
| COAG | Hemab Therapeutics Holdings, Inc. | 未评级 | US$542.3M | US$34.74 | — | — | — |
| VALN | Valneva SE | D- | US$532.8M | US$6.14 | — | US$177.9M | -73.7% |
| SLN | Silence Therapeutics plc | C- | US$528.2M | US$11.18 | — | US$615K | -9,748.5% |
| PRME | Prime Medicine, Inc. | C- | US$526M | US$2.90 | — | US$4.6M | -4,056.4% |
| CBIO | CRESCENT BIOPHARMA, INC. | D- | US$519.6M | US$13.99 | — | US$10.8M | -885.5% |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | US$504.3M | US$9.77 | 18.79 | US$231.2M | 11.6% |
| ANL | Adlai Nortye Ltd. | C | US$496.6M | US$15.53 | — | US$5M | -710.6% |
| ARVN | ARVINAS, INC. | B | US$496.3M | US$7.59 | 31.63 | US$316.7M | 2.9% |
| AUTL | Autolus Therapeutics plc | C- | US$493.7M | US$1.86 | — | US$117.4M | -238.7% |
| RGNX | REGENXBIO Inc. | D- | US$488.5M | US$7.40 | — | US$174.5M | -112.6% |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | US$486M | US$8.36 | — | US$0.00 | — |
| PBLS | Parabilis Medicines, Inc. | 未评级 | US$485.3M | US$31.20 | — | — | — |
| OCS | Oculis Holding AG | 未评级 | US$484.3M | US$9.27 | — | — | — |
| ASMB | Assembly Biosciences, Inc. | B- | US$481.9M | US$23.67 | 23.21 | US$72.3M | -0.1% |
| TECX | TECTONIC THERAPEUTIC, INC. | 未评级 | US$462.7M | US$23.67 | — | — | — |
| MPLT | MapLight Therapeutics, Inc. | 未评级 | US$443.9M | US$10.46 | — | — | — |
| AVLN | Avalyn Pharma Inc. | 未评级 | US$435.8M | US$28.08 | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | 未评级 | US$429M | US$7.92 | — | — | — |
| DMAC | DiaMedica Therapeutics Inc. | 未评级 | US$428.2M | US$7.94 | — | — | — |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | C- | US$425.6M | US$8.29 | — | US$54.5M | -80.7% |
| KYTX | Kyverna Therapeutics, Inc. | 未评级 | US$421.2M | US$6.81 | — | — | — |
| AVIR | Atea Pharmaceuticals, Inc. | 未评级 | US$414.7M | US$5.17 | — | — | — |
| SPTX | Seaport Therapeutics, Inc. | 未评级 | US$411.4M | US$21.52 | — | — | — |
| RLMD | RELMADA THERAPEUTICS, INC. | 未评级 | US$408.5M | US$3.83 | — | — | — |
| SPRY | ARS Pharmaceuticals, Inc. | D- | US$405.7M | US$4.08 | — | US$116.9M | -184.2% |
| YDES | YD Bio Limited | D | US$405.6M | US$5.73 | — | US$596.8K | -1,392.6% |
| SGMT | Sagimet Biosciences Inc. | 未评级 | US$396.3M | US$9.24 | — | — | — |
| EDIT | EDITAS MEDICINE, INC. | B- | US$396.2M | US$2.58 | — | US$47M | -157.3% |
| IRD | Opus Genetics, Inc. | F- | US$396M | US$4.76 | — | US$9.9M | -1,091.8% |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | US$393.7M | US$13.85 | — | US$29.4M | -317.6% |
| GALT | GALECTIN THERAPEUTICS INC. | 未评级 | US$393.3M | US$3.90 | — | — | — |
| ZURA | ZURA BIO LIMITED | 未评级 | US$387.1M | US$4.04 | — | — | — |
| AGEN | AGENUS INC | C | US$384.5M | US$8.54 | 3.31 | US$132.7M | 69.3% |
| RZLT | REZOLUTE, INC. | 未评级 | US$377.2M | US$3.90 | — | — | — |
| TTRX | Turn Therapeutics Inc. | 未评级 | US$372.1M | US$12.49 | — | — | — |
| FENC | FENNEC PHARMACEUTICALS INC. | C- | US$371.9M | US$10.61 | — | US$59.2M | -5.5% |
| ODTX | Odyssey Therapeutics, Inc. | 未评级 | US$369.9M | US$20.51 | — | — | — |
| CCCC | C4 Therapeutics, Inc. | C- | US$366.6M | US$2.98 | — | US$35M | -289.4% |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | US$357.6M | US$5.95 | — | US$32M | -184.6% |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | 未评级 | US$356.3M | US$51.80 | — | — | — |
| CABA | CABALETTA BIO, INC. | 未评级 | US$351M | US$2.07 | — | — | — |
| SRZN | Surrozen, Inc./DE | D | US$347.2M | US$29.54 | — | US$11.5M | -2,885.3% |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | US$346M | US$11.88 | — | US$65.3M | -96.9% |
| OCGN | OCUGEN, INC. | C | US$345.9M | US$1.02 | — | US$4.6M | -1,786.3% |
| ARTV | Artiva Biotherapeutics, Inc. | F- | US$341.7M | US$6.99 | — | US$0.00 | — |
| IMUX | Immunic, Inc. | 未评级 | US$339.8M | US$9.35 | — | — | — |
| BNTC | Benitec Biopharma Inc. | D | US$334.5M | US$9.59 | — | US$0.00 | — |
| LRMR | LARIMAR THERAPEUTICS, INC. | 未评级 | US$319.4M | US$3.08 | — | — | — |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 未评级 | US$316.7M | US$3.95 | — | — | — |
| VERU | VERU INC. | 未评级 | US$313.4M | US$2.54 | — | — | — |
| EYPT | EyePoint, Inc. | F- | US$312.1M | US$3.62 | — | US$2.8M | -10,994.7% |
| GTBP | GT BIOPHARMA, INC. | 未评级 | US$310.8M | US$6.89 | 18.61 | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | US$309.2M | US$3.88 | — | US$22.4M | -269.7% |
| ABEO | ABEONA THERAPEUTICS INC. | C- | US$308.8M | US$5.40 | — | US$25.5M | -246.4% |
| EVMN | Evommune, Inc. | D- | US$308.1M | US$8.49 | — | US$10M | -946.7% |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | US$305.3M | US$5.05 | — | US$215.7M | -127.4% |
| IPSC | Century Therapeutics, Inc. | B- | US$302.4M | US$1.67 | — | US$109.2M | -100.6% |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | US$299.3M | US$3.29 | — | US$0.00 | — |
| XFOR | X4 PHARMACEUTICALS, INC | D- | US$298.4M | US$3.01 | — | US$15.8M | -568.8% |
| KARD | Kardigan, Inc. | 未评级 | US$294.3M | US$14.79 | — | — | — |
| UPB | UPSTREAM BIO, INC. | D- | US$293.6M | US$5.36 | — | US$3.2M | -4,955.7% |
| CTNM | Contineum Therapeutics, Inc. | D | US$290.1M | US$12.56 | — | US$0.00 | — |
| IKT | Inhibikase Therapeutics, Inc. | F | US$287.4M | US$2.06 | — | US$0.00 | — |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | US$285.5M | US$8.01 | — | US$0.00 | — |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | US$285.4M | US$3.74 | — | US$0.00 | — |
| RCKT | Rocket Pharmaceuticals, Inc. | D | US$284.9M | US$2.60 | — | US$0.00 | — |
| LIMN | LIMINATUS PHARMA, INC. | 未评级 | US$281.7M | US$4.20 | — | — | — |
| FATE | FATE THERAPEUTICS INC | D- | US$281.6M | US$2.35 | — | US$6.5M | -1,941.1% |
| IMRX | Immuneering Corporation | 未评级 | US$276.2M | US$4.27 | — | — | — |
| IVVD | INVIVYD, INC. | C- | US$275.4M | US$0.93 | — | US$58.4M | -183.9% |
| HELP | CYBIN INC. | 未评级 | US$272.4M | US$12.61 | — | — | — |
| LXEO | Lexeo Therapeutics, Inc. | 未评级 | US$271.6M | US$3.31 | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | 未评级 | US$267.4M | US$18.22 | — | — | — |
| STRO | SUTRO BIOPHARMA, INC. | F | US$265M | US$15.98 | — | US$45.7M | -395.2% |
| QTTB | Q32 Bio Inc. | B | US$261.1M | US$8.77 | 2.80 | US$53.7M | 62.9% |
| LCTX | Lineage Cell Therapeutics, Inc. | D- | US$260.5M | US$1.03 | — | US$13.1M | -246.6% |
| BCYC | Bicycle Therapeutics plc | D- | US$257M | US$3.69 | — | US$61.2M | -311.1% |
| ACIU | AC IMMUNE SA | F- | US$256.4M | US$2.52 | — | US$4.3M | -1,207.8% |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | US$254M | US$12.86 | — | US$0.00 | — |
| PALI | PALISADE BIO, INC. | C- | US$252.7M | US$1.45 | — | US$500K | -6,388.2% |
| INDP | Indaptus Therapeutics, Inc. | 未评级 | US$246.8M | US$3.85 | — | — | — |
| CAMP | CAMP4 Therapeutics Corporation | B- | US$246M | US$3.92 | — | US$3.5M | -3,065.9% |
| LYEL | Lyell Immunopharma, Inc. | D- | US$241.4M | US$9.85 | — | US$27K | -920,285.2% |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | US$239.8M | US$6.16 | — | US$4.7M | -3,537.7% |
| PYXS | Pyxis Oncology, Inc. | D- | US$238.5M | US$2.86 | — | US$13.9M | -640.3% |
| MGNX | MACROGENICS, INC. | C- | US$238.2M | US$3.74 | — | US$167.7M | -8.7% |
| SION | SIONNA THERAPEUTICS, INC. | 未评级 | US$236.5M | US$5.23 | — | — | — |
| KROS | Keros Therapeutics, Inc. | D- | US$230.4M | US$11.62 | — | US$15M | -553.9% |
| CUE | Cue Biopharma, Inc. | D- | US$228.2M | US$31.41 | — | US$37.7M | -435.8% |
| NRSN | NeuroSense Therapeutics Ltd. | 未评级 | US$226.3M | US$6.95 | — | — | — |
| CGEN | COMPUGEN LTD | B+ | US$225M | US$2.38 | 6.26 | US$74M | 47.6% |
| RNAC | Cartesian Therapeutics, Inc. | F | US$224.2M | US$7.41 | — | US$1.5M | -10,283.8% |
| ZLAB | ZAI LAB LIMITED | C- | US$221.3M | US$24.98 | — | US$449.6M | -41.9% |
| AVXL | ANAVEX LIFE SCIENCES CORP. | 未评级 | US$220.6M | US$2.38 | — | — | — |
| PLX | Protalix BioTherapeutics, Inc. | A+ | US$219.2M | US$2.72 | 11.83 | US$80.6M | 23.5% |
| ALEC | Alector, Inc. | D- | US$217.7M | US$1.95 | — | US$13.9M | -850.1% |
| MLEC | MOOLEC SCIENCE SA | D | US$217.4M | US$5.60 | — | US$333.6M | -52.9% |
| ELDN | Eledon Pharmaceuticals, Inc. | 未评级 | US$215.3M | US$2.65 | — | — | — |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | US$213.2M | US$3.74 | — | US$0.00 | — |
| FHTX | Foghorn Therapeutics Inc. | B | US$207.8M | US$3.50 | — | US$36.7M | -175.8% |
| CMPX | COMPASS THERAPEUTICS, INC. | F | US$203.5M | US$1.13 | — | US$0.00 | — |
| NKTX | Nkarta, Inc. | D | US$197M | US$2.75 | — | US$0.00 | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | US$196.8M | US$4.73 | 1.15 | US$2M | 8,743.5% |
| TARA | Protara Therapeutics, Inc. | 未评级 | US$193.8M | US$3.28 | — | — | — |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | US$193.5M | US$2.70 | — | US$0.00 | — |
| SLGL | Sol-Gel Technologies Ltd. | B | US$186.3M | US$66.85 | — | US$1.8M | -341.3% |
| ACOG | Alpha Cognition Inc. | D- | US$184.5M | US$8.47 | — | US$15.3M | -153.6% |
| ANTX | AN2 Therapeutics, Inc. | 未评级 | US$184.2M | US$4.88 | — | — | — |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 未评级 | US$181.1M | US$1.31 | — | — | — |
| PEPG | PEPGEN INC. | 未评级 | US$179.4M | US$2.59 | — | — | — |
| MDWD | MEDIWOUND LTD. | F- | US$177.6M | US$13.84 | — | US$11.9M | -170.1% |
| CHRS | Coherus Oncology, Inc. | B | US$174.6M | US$1.13 | — | US$50.9M | -259.4% |
| PRQR | ProQR Therapeutics N.V. | C- | US$173.8M | US$1.65 | — | US$20.9M | -229.7% |
| MOLN | MOLECULAR PARTNERS AG | F- | US$173.6M | US$4.30 | — | US$5.2M | -1,437.4% |
| ADAG | Adagene Inc. | C- | US$173.5M | US$2.93 | — | US$7.7M | -229.6% |
| DTIL | PRECISION BIOSCIENCES INC | D- | US$171.7M | US$6.22 | — | US$45.1M | -117.0% |
| OVID | Ovid Therapeutics Inc. | C- | US$170.1M | US$2.40 | — | US$1.6M | -2,178.9% |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | US$169.1M | US$9.86 | — | US$29.1M | -548.6% |
| VYGR | Voyager Therapeutics, Inc. | F- | US$165.1M | US$2.68 | — | US$34.5M | -312.6% |
| NERV | Minerva Neurosciences, Inc. | F | US$162.3M | US$3.40 | — | US$0.00 | — |
| ABOS | Acumen Pharmaceuticals, Inc. | 未评级 | US$162M | US$2.24 | — | — | — |
| IPHA | Innate Pharma SA | F- | US$159.3M | US$1.70 | — | US$10.2M | -546.1% |
| NBP | NovaBridge Biosciences | 未评级 | US$159.2M | US$1.38 | — | — | — |
| HUMA | Humacyte, Inc. | C- | US$154.8M | US$0.56 | — | US$2.1M | -4,560.8% |
| NGEN | NERVGEN PHARMA CORP. | 未评级 | US$154.5M | US$1.94 | — | — | — |
| MENS | Jyong Biotech Ltd. | 未评级 | US$154.3M | US$2.03 | — | — | — |
| CURX | Curanex Pharmaceuticals Inc | 未评级 | US$148.7M | US$4.74 | — | — | — |
| CLLS | Cellectis S.A. | C- | US$147.4M | US$1.47 | — | US$72.9M | -92.7% |
| BRVE | Braveheart Bio, Inc. | 未评级 | US$147.1M | US$20.62 | — | — | — |
| KRSA | CYCLERION THERAPEUTICS, INC. | F- | US$145.1M | US$31.00 | — | US$1.9M | -353.0% |
| CDXS | Codexis, Inc. | D- | US$144.5M | US$1.32 | — | US$77.7M | -39.6% |
| RNA | Atrium Therapeutics, Inc. | 未评级 | US$141.8M | US$8.29 | — | — | — |
| KRRO | Korro Bio, Inc. | C- | US$140.9M | US$9.57 | — | US$2.4M | -4,477.1% |
| SPRB | Spruce Biosciences, Inc. | F | US$140M | US$48.72 | — | US$0.00 | — |
| ARMP | ARMATA PHARMACEUTICALS, INC. | 未评级 | US$139.1M | US$3.74 | — | — | — |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 未评级 | US$138.1M | US$7.14 | — | — | — |
| TNYA | Tenaya Therapeutics, Inc. | 未评级 | US$136.7M | US$0.61 | — | — | — |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | US$136.7M | US$0.76 | — | US$4.9M | -618.0% |
| IFRX | InflaRx N.V. | F- | US$136.6M | US$1.89 | — | US$33.4K | -155,582.1% |
| ENTX | ENTERA BIO LTD. | F | US$134.8M | US$2.75 | — | US$0.00 | — |
| MSLE | Satellos Bioscience Inc. | 未评级 | US$134.5M | US$8.70 | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | US$133.8M | US$2.10 | — | US$0.00 | — |
| CRBU | Caribou Biosciences, Inc. | D- | US$132.9M | US$1.24 | — | US$10M | -1,030.4% |
| ENGN | enGene Therapeutics Inc. | 未评级 | US$131.4M | US$1.96 | — | — | — |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | 未评级 | US$130.8M | US$4.70 | — | — | — |
| NMRA | NEUMORA THERAPEUTICS, INC. | 未评级 | US$127.3M | US$0.68 | — | — | — |
| MNOV | MEDICINOVA, INC. | C- | US$127M | US$2.58 | — | US$920.5K | -1,168.2% |
| VOGX | Vogenx, Inc. | 未评级 | US$123.9M | US$22.73 | — | — | — |
| LENZ | LENZ THERAPEUTICS, INC. | D- | US$123M | US$3.92 | — | US$19.1M | -660.1% |
| NAUT | Nautilus Biotechnology, Inc. | 未评级 | US$122.5M | US$0.96 | — | — | — |
| INO | INOVIO PHARMACEUTICALS, INC. | D | US$122M | US$1.18 | — | US$0.00 | — |
| TLSA | Tiziana Life Sciences Ltd | 未评级 | US$121.7M | US$1.01 | — | — | — |
| COYA | Coya Therapeutics, Inc. | F- | US$119.2M | US$5.08 | — | US$8M | -270.2% |
| OKUR | ONKURE THERAPEUTICS, INC. | C | US$117.4M | US$2.90 | — | US$0.00 | — |
| GNLX | GENELUX CORPORATION | F- | US$112.2M | US$2.48 | — | US$8K | -444,950.0% |
| VANI | Vivani Medical, Inc. | F | US$111.9M | US$1.24 | — | US$0.00 | — |
| AARD | AARDVARK THERAPEUTICS, INC. | F | US$110.7M | US$5.06 | — | US$0.00 | — |
| CNXU | CONEXEU SCIENCES INC. | 未评级 | US$109.7M | US$3.89 | — | — | — |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | D | US$108M | US$1.88 | — | US$0.00 | — |
| EQ | EQUILLIUM, INC. | C- | US$105.9M | US$1.67 | — | US$41.1M | -43.8% |
| SEER | SEER, INC. | D- | US$105.8M | US$1.91 | — | US$14.2M | -478.0% |
| PLYX | Polaryx Therapeutics, Inc. | 未评级 | US$104.2M | US$2.09 | — | — | — |
| QNCX | Quince Therapeutics, Inc. | 未评级 | US$102.2M | US$31.00 | — | — | — |
| PMN | PROMIS NEUROSCIENCES INC. | 未评级 | US$101.1M | US$11.27 | — | — | — |
| PROK | ProKidney Corp. | F- | US$98.5M | US$1.60 | — | US$818K | -10,288.4% |
| MIST | Milestone Pharmaceuticals Inc. | 未评级 | US$98.2M | US$0.79 | — | — | — |
| FTH | Faeth Therapeutics, Inc. | 未评级 | US$97.5M | US$28.00 | — | — | — |
| NTRB | NUTRIBAND INC. | F- | US$97.2M | US$8.00 | — | US$1.6M | -430.4% |
| ANIX | ANIXA BIOSCIENCES, INC. | 未评级 | US$96.6M | US$2.78 | — | — | — |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | US$96.5M | US$1.24 | — | US$508K | -7,884.1% |
| BMEA | Biomea Fusion, Inc. | 未评级 | US$95.7M | US$1.32 | — | — | — |
| PYPD | PolyPid Ltd | 未评级 | US$95M | US$5.22 | 2.50 | — | — |
| NRXS | NEURAXIS, INC. | D- | US$94.9M | US$7.56 | — | US$5.3M | -144.4% |
| ICCC | ImmuCell Corporation | A | US$90.1M | US$9.93 | 141.79 | US$30.7M | 2.6% |
| ACRV | Acrivon Therapeutics, Inc. | 未评级 | US$90M | US$2.10 | — | — | — |
| CGTX | Cognition Therapeutics, Inc. | 未评级 | US$89.1M | US$0.94 | — | — | — |
| ATRA | ATARA BIOTHERAPEUTICS, INC. | D | US$88.4M | US$8.81 | — | US$6.2M | -269.4% |
| RLYB | RALLYBIO CORPORATION | D | US$88.3M | US$16.62 | 3.38 | US$646K | 7,051.2% |
| ONCY | ONCOLYTICS BIOTECH INC. | 未评级 | US$87.1M | US$0.68 | — | — | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | US$85.8M | US$3.31 | — | US$40K | -118,029.5% |
| PTHS | Pelthos Therapeutics Inc. | C- | US$85M | US$22.19 | — | US$50.4M | -171.4% |
| TELO | Telomir Pharmaceuticals, Inc. | 未评级 | US$84.6M | US$1.23 | — | — | — |
| ACET | Adicet Bio, Inc. | 未评级 | US$84.4M | US$9.02 | — | — | — |
| FBIO | Fortress Biotech, Inc. | B | US$84.4M | US$2.28 | 0.86 | US$68.5M | 163.3% |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | US$81.3M | US$3.28 | — | US$194K | -3,985.6% |
| GANX | GAIN THERAPEUTICS, INC | 未评级 | US$77.7M | US$1.78 | — | — | — |
| GUTS | Fractyl Health, Inc. | F- | US$77.3M | US$0.49 | — | US$0.00 | — |
| OSTX | OS THERAPIES INCORPORATED | 未评级 | US$76.6M | US$1.66 | — | — | — |
| IBIO | IBIO, INC. | D- | US$76.5M | US$1.19 | — | US$100K | -33,044.0% |
| VRCA | Verrica Pharmaceuticals Inc. | C- | US$75.1M | US$4.37 | — | US$30.3M | -102.8% |
| RNXT | RENOVORX, INC. | D- | US$74.9M | US$1.66 | — | US$2M | -621.7% |
| ATTO | Attovia Therapeutics, Inc. | 未评级 | US$74.6M | US$17.78 | — | — | — |
| BSEM | BioStem Technologies, Inc. | D- | US$73.9M | US$4.14 | — | US$34.6M | -81.8% |
| MAIA | MAIA Biotechnology, Inc. | F | US$73M | US$1.20 | — | US$0.00 | — |
| ALDX | ALDEYRA THERAPEUTICS, INC. | 未评级 | US$72.7M | US$1.21 | — | — | — |
| OKYO | OKYO Pharma Limited | 未评级 | US$72.4M | US$1.38 | — | — | — |
| SPRO | Spero Therapeutics, Inc. | C | US$71.6M | US$1.23 | 8.79 | US$47M | 15.7% |
| PMVP | PMV PHARMACEUTICALS, INC. | 未评级 | US$71.1M | US$1.33 | — | — | — |
| CING | Cingulate Inc. | 未评级 | US$70.2M | US$4.83 | — | — | — |
| LNAI | Lunai Bioworks Inc. | 未评级 | US$70M | US$1.93 | — | — | — |
| LONA | LeonaBio, Inc. | 未评级 | US$69.5M | US$3.25 | — | — | — |
| KLRS | KALARIS THERAPEUTICS, INC. | 未评级 | US$69.5M | US$2.92 | — | — | — |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | US$68.2M | US$4.90 | — | US$60.7M | -1.8% |
| CNTB | Connect Biopharma Holdings Limited | C- | US$68M | US$1.08 | — | US$3M | -2,336.3% |
| TENX | TENAX THERAPEUTICS, INC. | F | US$67.7M | US$1.81 | — | US$0.00 | — |
| PLRX | PLIANT THERAPEUTICS, INC. | D | US$66.9M | US$1.08 | — | US$0.00 | — |
| XBIT | XBIOTECH INC. | 未评级 | US$66.2M | US$2.17 | — | — | — |
| ALPS | ALPS GROUP INC | 未评级 | US$65.9M | US$0.40 | — | — | — |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | US$65M | US$2.55 | — | US$357.9K | -3,089.6% |
| RNTX | Rein Therapeutics, Inc. | F | US$64.6M | US$0.75 | — | US$0.00 | — |
| HYFT | MindWalk Holdings Corp. | C- | US$64.5M | US$1.38 | — | US$19.8M | -43.6% |
| HYPD | HYPERION DEFI, INC. | D+ | US$62.8M | US$4.04 | — | US$1.4M | 474.9% |
| INKT | MiNK Therapeutics, Inc. | 未评级 | US$62.2M | US$12.18 | — | — | — |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | US$60.7M | US$15.03 | — | US$0.00 | — |
| BOLD | BOUNDLESS BIO, INC. | 未评级 | US$60.5M | US$2.66 | — | — | — |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | US$59.6M | US$0.64 | — | -US$1.2M | 5,253.5% |
| SKYE | Skye Bioscience, Inc. | 未评级 | US$59.2M | US$1.67 | — | — | — |
| MREO | MEREO BIOPHARMA GROUP PLC | B | US$59.1M | US$0.37 | — | US$500K | -5,619.8% |
| EXOZ | EXOZYMES INC. | 未评级 | US$58M | US$6.25 | — | — | — |
| ALGS | Aligos Therapeutics, Inc. | D- | US$57.4M | US$5.51 | — | US$3.7M | -2,031.1% |
| INMB | INMUNE BIO INC. | D- | US$56.3M | US$2.03 | — | US$50K | -36,832.0% |
| BCAB | BIOATLA, INC. | 未评级 | US$56.1M | US$1.74 | — | — | — |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | C- | US$55.9M | US$0.29 | — | US$151.2M | -22.5% |
| ANVS | Annovis Bio, Inc. | F | US$55.8M | US$1.31 | — | US$0.00 | — |
| CLNN | Clene Inc. | D | US$55.2M | US$4.30 | — | US$197K | -20,059.9% |
| CLGN | CollPlant Biotechnologies Ltd | B- | US$54.4M | US$4.25 | — | US$2.4M | -484.6% |
| IMA | ImageneBio, Inc. | D- | US$53.6M | US$4.72 | — | US$800K | -6,560.5% |
| SER | Serina Therapeutics, Inc. | D | US$53.1M | US$2.09 | — | US$130K | -16,288.5% |
| SCTX | SCRIBE THERAPEUTICS INC. | 未评级 | US$52.5M | US$21.28 | — | — | — |
| XLO | Xilio Therapeutics, Inc. | C- | US$52.3M | US$9.04 | — | US$64.1M | -34.1% |
| BLSM | BlossomHill Therapeutics, Inc. | 未评级 | US$52.3M | US$19.75 | — | — | — |
| LITS | Lite Strategy, Inc. | D | US$49M | US$1.44 | — | US$0.00 | — |
| TIL | Instil Bio, Inc. | C- | US$48.6M | US$7.17 | — | US$9M | -337.7% |
| ELTX | Elicio Therapeutics, Inc. | 未评级 | US$48.4M | US$1.84 | — | — | — |
| TVGN | Tevogen Inc. | 未评级 | US$47.2M | US$7.25 | — | — | — |
| HOWL | WEREWOLF THERAPEUTICS, INC. | 未评级 | US$46.7M | US$0.96 | — | — | — |
| DWTX | Dogwood Therapeutics, Inc. | 未评级 | US$46.2M | US$1.36 | — | — | — |
| PDSB | PDS Biotechnology Corp | 未评级 | US$44.6M | US$0.80 | — | — | — |
| GRCE | Grace Therapeutics, Inc. | 未评级 | US$44.6M | US$2.12 | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | US$44.2M | US$0.34 | — | US$7.1M | -1,655.4% |
| MGX | Metagenomi Therapeutics, Inc. | D- | US$43.4M | US$1.15 | — | US$22.3M | -418.5% |
| KAPA | KAIROS PHARMA, LTD. | 未评级 | US$40.8M | US$1.72 | — | — | — |
| CELU | Celularity Inc. | C | US$39.9M | US$1.38 | — | US$26.6M | -345.4% |
| ATHE | ALTERITY THERAPEUTICS LTD | 未评级 | US$39.1M | US$3.67 | — | — | — |
| EDSA | EDESA BIOTECH, INC. | 未评级 | US$38.7M | US$4.01 | — | — | — |
| IMMP | Immutep Limited | D- | US$38.5M | US$0.26 | — | US$7.3M | -594.6% |
| CRVO | CervoMed Inc. | F- | US$38.4M | US$2.54 | — | US$331.3K | -9,160.9% |
| ATNM | ACTINIUM PHARMACEUTICALS, INC. | D+ | US$37.7M | US$1.20 | 3.33 | US$90K | 12,564.4% |
| ELAB | PMGC HOLDINGS INC. | D- | US$37M | US$4.57 | — | US$2.6M | -523.0% |
| FLNA | Filana Therapeutics, Inc. | 未评级 | US$36.1M | US$0.75 | — | — | — |
| NIKI | Niki BioSolutions, Inc. | 未评级 | US$35M | US$4.76 | — | — | — |
| MCRB | Seres Therapeutics, Inc. | D- | US$35M | US$3.52 | — | US$1.9M | -1,192.9% |
| ICU | SeaStar Medical Holding Corp | D- | US$34.1M | US$3.42 | — | US$1.7M | -795.5% |
| BYSI | BeyondSpring Inc. | D | US$32M | US$0.78 | — | US$0.00 | — |
| CNTX | CONTEXT THERAPEUTICS INC. | 未评级 | US$31.8M | US$0.35 | — | — | — |
| NNVC | NANOVIRICIDES, INC. | F | US$31.2M | US$1.44 | — | US$0.00 | — |
| ABVC | ABVC BioPharma, Inc. | D- | US$30.1M | US$1.13 | — | US$296K | -2,400.9% |
| ATYR | aTYR PHARMA INC | F- | US$29.9M | US$0.31 | — | US$190K | -32,003.7% |
| CVM | CEL-SCI CORPORATION | 未评级 | US$29.4M | US$1.67 | — | — | — |
| IGC | IGC PHARMA, INC. | C- | US$29.2M | US$0.28 | — | US$1.3M | -560.3% |
| ENLV | Enlivex Ltd. | 未评级 | US$29M | US$0.60 | 0.02 | — | — |
| CALC | CalciMedica, Inc. | 未评级 | US$28.8M | US$1.75 | — | — | — |
| KYNB | KYNTRA BIO, INC. | F | US$28.1M | US$6.94 | 0.15 | US$4.6M | 3,967.8% |
| EVAX | Evaxion A/S | B- | US$27.9M | US$3.34 | — | US$7.5M | -102.4% |
| NRXP | NRX Pharmaceuticals, Inc. | B | US$26.5M | US$3.00 | — | US$3.4M | -691.8% |
| APRE | Aprea Therapeutics, Inc. | 未评级 | US$26M | US$0.76 | — | — | — |
| APLM | Apollomics Inc. | B | US$24.7M | US$22.35 | — | US$8.5M | -128.7% |
| GRDX | GRIDAI TECHNOLOGIES CORP | F- | US$24.5M | US$3.43 | — | US$36.3K | -56,864.0% |
| NXTC | NEXTCURE, INC | 未评级 | US$23.3M | US$5.08 | — | — | — |
| COCP | COCRYSTAL PHARMA, INC. | 未评级 | US$22.5M | US$1.17 | — | — | — |
| YARW | YARROW BIOSCIENCE, INC. | C- | US$21.9M | US$25.54 | — | US$570K | -4,646.1% |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | 未评级 | US$20.9M | US$0.48 | — | — | — |
| JSPR | JASPER THERAPEUTICS, INC. | 未评级 | US$20.3M | US$0.61 | — | — | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | US$19.2M | US$1.15 | — | US$3.9M | -220.5% |
| ATOS | ATOSSA THERAPEUTICS, INC. | 未评级 | US$19M | US$1.90 | — | — | — |
| CNSP | CNS Pharmaceuticals, Inc. | 未评级 | US$18.6M | US$4.93 | — | — | — |
| PTN | PALATIN TECHNOLOGIES, INC. | B | US$18M | US$10.10 | — | US$12.9M | -48.6% |
| LPCN | LIPOCINE INC. | C- | US$17.3M | US$2.10 | — | US$1.6M | -755.1% |
| BCTX | BRIACELL THERAPEUTICS CORP. | 未评级 | US$17M | US$4.32 | — | — | — |
| CLRB | Cellectar Biosciences, Inc. | 未评级 | US$17M | US$1.80 | — | — | — |
| TVRD | TVARDI THERAPEUTICS, INC. | C- | US$16.9M | US$1.27 | — | US$7.6M | -344.2% |
| KTTA | PASITHEA THERAPEUTICS CORP. | 未评级 | US$16.7M | US$0.50 | — | — | — |
| ACTU | Actuate Therapeutics, Inc. | 未评级 | US$16.3M | US$0.68 | — | — | — |
| BCDA | BioCardia, Inc. | F | US$15.9M | US$1.05 | — | US$0.00 | — |
| CTXR | Citius Pharmaceuticals, Inc. | 未评级 | US$15.9M | US$0.58 | — | — | — |
| LTGO | Latigo Biotherapeutics, Inc. | 未评级 | US$15.8M | US$17.15 | — | — | — |
| LTRN | Lantern Pharma Inc. | 未评级 | US$15.6M | US$1.22 | — | — | — |
| CMMB | SNOWDRIFT PARENT CORPORATION | 未评级 | US$15.5M | US$2.16 | 120.00 | — | — |
| KZIA | Kazia Therapeutics Limited. | F | US$15.5M | US$9.57 | 8.43 | US$29.5K | -54,287.3% |
| PASG | PASSAGE BIO, INC. | 未评级 | US$15.4M | US$4.80 | — | — | — |
| DYAI | DYADIC INTERNATIONAL INC | F- | US$15.2M | US$0.42 | — | US$3.8M | -200.5% |
| CNSY | CERENOME, INC. | F- | US$15.1M | US$1.99 | — | US$4.2M | -620.7% |
| HIND | VYOME HOLDINGS, INC. | F- | US$14.3M | US$2.04 | — | US$129.7K | -8,716.8% |
| LSTA | LISATA THERAPEUTICS, INC. | C- | US$14.2M | US$1.58 | — | US$100K | -14,621.0% |
| NCEL | NewcelX Ltd. | 未评级 | US$14.1M | US$2.95 | 1.36 | — | — |
| AEON | AEON Biopharma, Inc. | 未评级 | US$13.1M | US$0.26 | — | — | — |
| RADX | Radiopharm Theranostics Limited | F- | US$13M | US$1.65 | — | US$3.6M | -1,055.3% |
| PLUR | Pluri Inc. | D | US$12.5M | US$1.01 | — | US$1M | -2,344.6% |
| INTS | INTENSITY THERAPEUTICS, INC. | 未评级 | US$12.4M | US$3.80 | — | — | — |
| TPST | Tempest Therapeutics, Inc. | 未评级 | US$12.3M | US$0.83 | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | US$12.1M | US$0.27 | — | US$2.5M | -2,702.6% |
| BIVI | BioVie Inc. | 未评级 | US$12.1M | US$1.61 | — | — | — |
| DARE | Dare Bioscience, Inc. | C- | US$11.9M | US$0.78 | — | US$1.4M | -804.4% |
| INAB | IN8BIO, INC. | 未评级 | US$11.8M | US$1.20 | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | US$11.7M | US$0.60 | — | US$0.00 | — |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | US$11.6M | US$2.63 | — | US$0.00 | — |
| BLRX | BioLineRx Ltd | C- | US$11.3M | US$2.60 | — | US$1.2M | -171.7% |
| GDTC | CytoMed Therapeutics Limited | D- | US$11.3M | US$0.96 | — | US$253.9K | -1,227.1% |
| ADIL | Adial Pharmaceuticals, Inc. | 未评级 | US$11.1M | US$4.22 | — | — | — |
| MTVA | METAVIA INC. | 未评级 | US$10.9M | US$1.66 | — | — | — |
| SNTI | Senti Biosciences Holdings, Inc. | F- | US$10.3M | US$0.33 | — | US$22K | -225,290.9% |
| TOVX | Theriva Biologics, Inc. | 未评级 | US$10.1M | US$0.22 | — | — | — |
| IMRN | IMMURON LIMITED | D- | US$9.4M | US$1.16 | — | US$5.1M | -71.6% |
| FBLG | FibroBiologics, Inc. | 未评级 | US$9.3M | US$1.39 | — | — | — |
| KALA | KALA BIO, INC. | F | US$9.2M | US$0.48 | — | US$0.00 | — |
| VRAX | Virax Biolabs Group Ltd | C- | US$8.9M | US$2.40 | — | US$6.3K | -95,739.2% |
| ALZN | ALZAMEND NEURO, INC. | 未评级 | US$8.8M | US$1.83 | — | — | — |
| TRAW | Traws Pharma, Inc. | C- | US$8.7M | US$0.56 | — | US$2.8M | -773.0% |
| SNGX | SOLIGENIX, INC. | D- | US$8.4M | US$0.38 | — | US$119.4K | -8,577.8% |
| ENSC | ENSYSCE BIOSCIENCES, INC. | D- | US$8M | US$0.41 | — | US$4.5M | -280.5% |
| XCUR | EXICURE, INC. | F | US$8M | US$1.22 | — | US$0.00 | — |
| IMNN | Imunon, Inc. | 未评级 | US$7.9M | US$1.41 | — | — | — |
| ALLR | Allarity Therapeutics, Inc. | B- | US$7.9M | US$1.03 | — | US$320K | -3,854.4% |
| ARTL | ARTELO BIOSCIENCES, INC. | 未评级 | US$7.9M | US$4.54 | — | — | — |
| CBUS | Cibus, Inc. | C- | US$7.6M | US$1.52 | — | US$4.3M | -2,258.9% |
| ACXP | Acurx Pharmaceuticals, Inc. | 未评级 | US$7.2M | US$1.36 | — | — | — |
| BOLT | Bolt Biotherapeutics, Inc. | D- | US$6.9M | US$3.58 | — | US$4.7M | -611.5% |
| CELZ | Creative Medical Technology Holdings, Inc. | D- | US$6.8M | US$1.03 | — | US$3K | -201,355.4% |
| ENVB | ENVERIC BIOSCIENCES, INC. | 未评级 | US$6.7M | US$1.50 | — | — | — |
| PULM | PULMATRIX, INC. | B- | US$5.9M | US$1.61 | — | US$7.8M | -51.4% |
| CDIO | Cardio Diagnostics Holdings, Inc. | C- | US$5.8M | US$1.95 | — | US$14.5K | -44,771.8% |
| AGMB | AgomAb Therapeutics NV | 未评级 | US$5.7M | US$10.51 | — | — | — |
| ERNA | Ernexa Therapeutics Inc. | B- | US$5.6M | US$3.45 | — | US$582K | -2,106.0% |
| XBIO | XENETIC BIOSCIENCES, INC. | D- | US$5.6M | US$2.39 | — | US$3.3M | -75.9% |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | US$5.4M | US$1.55 | — | US$1.5M | -558.6% |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | US$5.2M | US$2.20 | — | US$451K | -1,545.2% |
| PCSA | Processa Pharmaceuticals, Inc. | 未评级 | US$5.1M | US$1.84 | — | — | — |
| PMCB | PHARMACYTE BIOTECH, INC. | D | US$4.7M | US$0.44 | — | US$0.00 | — |
| PHIO | PHIO PHARMACEUTICALS CORP. | 未评级 | US$4.6M | US$1.01 | — | — | — |
| DRMA | DERMATA THERAPEUTICS, INC. | 未评级 | US$4.6M | US$1.14 | — | — | — |
| ADXN | Addex Therapeutics Ltd | D- | US$4.5M | US$3.65 | — | US$36K | -22,448.4% |
| GRI | GRI BIO, INC. | 未评级 | US$4.5M | US$2.05 | — | — | — |
| QNTM | Quantum BioPharma Ltd. | 未评级 | US$4.4M | US$3.85 | — | — | — |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | US$4.1M | US$1.17 | — | US$1.1M | -729.9% |
| CVKD | Cadrenal Therapeutics, Inc. | 未评级 | US$4.1M | US$1.15 | — | — | — |
| OSRH | OSR HEALTH, INC. | D- | US$4.1M | US$0.12 | — | US$1.8M | -824.4% |
| EVGN | EVOGENE LTD. | D- | US$3.6M | US$0.42 | — | US$1.3M | -649.2% |
| HCWB | HCW Biologics Inc. | B- | US$3.5M | US$1.93 | — | US$6.7M | -83.8% |
| MBIO | MUSTANG BIO, INC. | 未评级 | US$3.5M | US$0.52 | — | — | — |
| REVB | REVELATION BIOSCIENCES, INC. | 未评级 | US$3.5M | US$0.87 | — | — | — |
| HLSQ | BiomX Inc. | 未评级 | US$3.4M | US$0.53 | — | — | — |
| APVO | Aptevo Therapeutics Inc. | 未评级 | US$3.4M | US$1.89 | — | — | — |
| PBM | PSYENCE BIOMEDICAL LTD | 未评级 | US$3.1M | US$5.56 | — | — | — |
| AZTR | Azitra, Inc. | F- | US$2.9M | US$0.17 | — | US$0.00 | — |
| SILO | SILO PHARMA, INC. | F- | US$2.8M | US$1.75 | — | US$54.1K | -8,269.5% |
| TCRT | Alaunos Therapeutics, Inc. | D- | US$2.8M | US$1.09 | — | US$3K | -133,666.7% |
| GNPX | Genprex, Inc. | D | US$2.7M | US$3.29 | — | US$0.00 | — |
| GOVX | GEOVAX LABS, INC. | D | US$2.6M | US$0.35 | — | US$0.00 | — |
| VBIO | Valion Bio, Inc. | F- | US$2.2M | US$3.03 | — | US$482K | -3,890.0% |
| OGEN | ORAGENICS, INC. | 未评级 | US$2.2M | US$0.49 | — | — | — |
| AIM | AIM IMMUNOTECH INC. | D | US$2.1M | US$0.19 | — | US$95K | -15,021.1% |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | US$2.1M | US$2.67 | — | US$21.8K | -42,206.9% |
| DCOY | Decoy Therapeutics Inc. | 未评级 | US$2M | US$3.09 | — | — | — |
| SPRC | SCISPARC LTD. | F- | US$1.9M | US$5.21 | — | US$856K | -1,422.8% |
| CANF | Can-Fite BioPharma Ltd. | F- | US$1.8M | US$2.16 | — | US$405K | -2,426.7% |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | 未评级 | US$1.8M | US$1.67 | — | — | — |
| CRIS | CURIS, INC. | F- | US$1.7M | US$0.83 | — | US$4.3M | -490.3% |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | 未评级 | US$1.6M | US$1.69 | — | — | — |
| BBLG | BONE BIOLOGICS CORPORATION | 未评级 | US$1.4M | US$0.50 | — | — | — |
| ONCO | Onconetix, Inc. | D- | US$1.2M | US$1.03 | — | US$645.8K | -1,578.8% |
| VIVS | VivoSim Labs, Inc. | D | US$1.2M | US$0.22 | — | US$112K | -11,016.1% |
| CLDI | Calidi Biotherapeutics, Inc. | 未评级 | US$1.2M | US$1.13 | — | — | — |
| QNRX | Quoin Pharmaceuticals Ltd. | 未评级 | US$1.1M | US$6.43 | — | — | — |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | 未评级 | US$1M | US$0.16 | — | — | — |
| CMND | Clearmind Medicine Inc. | 未评级 | US$933.2K | US$0.80 | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | 未评级 | US$708.3K | US$0.63 | — | — | — |
| KLRA | Kailera Therapeutics, Inc. | 未评级 | US$573.4K | US$11.22 | — | — | — |
| PLRZ | Polyrizon Ltd. | 未评级 | US$488.7K | US$10.78 | 2.20 | — | — |
| EDVA | SPLASH BEVERAGE GROUP, INC. | D | US$408.6K | US$0.19 | — | US$32.1K | -53,856.5% |
| BDRX | Biodexa Pharmaceuticals PLC | 未评级 | US$370.9K | US$0.68 | — | — | — |
| SLXN | SILEXION THERAPEUTICS CORP | 未评级 | US$131.8K | US$0.26 | — | — | — |
| NEUP | Neuphoria Therapeutics Inc. | F- | US$109.7K | US$3.65 | — | US$1.2M | -1,145.7% |
| KPTI | Karyopharm Therapeutics Inc. | B | US$41.3K | US$1.62 | — | US$146.6M | -153.3% |
| CDT | CDT EQUITY INC. | 未评级 | US$24.3K | US$0.08 | — | — | — |
| PPBT | PURPLE BIOTECH LTD. | 未评级 | US$362.44 | US$1.51 | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | 未评级 | — | US$19.35 | — | — | — |
| APGE | Apogee Therapeutics, Inc. | 未评级 | — | US$135.07 | — | — | — |
| ATAI | AtaiBeckley Inc. | 未评级 | — | US$7.35 | — | US$4.1M | -16,142.0% |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | US$0.74 | — | US$0.00 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | US$84.95 | — | US$42.2M | -1,189.9% |
| ETRA | Electra Therapeutics, Inc. | 未评级 | — | US$11.55 | — | — | — |
| FBRX | FORTE BIOSCIENCES, INC. | 未评级 | — | US$76.99 | — | — | — |
| SLBT | SL Science Holding Limited | 未评级 | — | US$1.57 | — | — | — |
| VCRE | Vicore Pharma Holding AB | 未评级 | — | US$9.65 | — | — | — |
| VRXA | Veraxa Biotech Holding AG | 未评级 | — | US$1.41 | — | — | — |
| VTVT | vTv Therapeutics Inc. | D- | — | US$30.21 | — | US$36.8M | -12.9% |
基本面来自 SEC 申报文件，价格来自最近一次行情更新。可按任意列排序；没有数值的公司在两个方向都排在末尾。
按市值从大到小排序；点击任意列可重新排序。没有数值的公司在两个方向都排在末尾，因为市盈率缺失意味着亏损，而不是便宜。这里没有任何内容构成推荐。